Sign In
Buy NATR
Nature Earnings Calls
| Release date | May 07, 2026 |
| EPS estimate | $0.205 |
| EPS actual | $0.300 |
| EPS Surprise | 46.34% |
| Revenue estimate | 122.15M |
| Revenue actual | 122.892M |
| Revenue Surprise | 0.607% |
| Release date | Mar 10, 2026 |
| EPS estimate | $0.185 |
| EPS actual | $0.300 |
| EPS Surprise | 62.16% |
| Revenue estimate | 121.503M |
| Revenue actual | 123.807M |
| Revenue Surprise | 1.90% |
| Release date | Nov 06, 2025 |
| EPS estimate | $0.190 |
| EPS actual | $0.360 |
| EPS Surprise | 89.47% |
| Revenue estimate | 121.621M |
| Revenue actual | 128.339M |
| Revenue Surprise | 5.52% |
| Release date | Jul 31, 2025 |
| EPS estimate | $0.180 |
| EPS actual | $0.350 |
| EPS Surprise | 94.44% |
| Revenue estimate | 119.386M |
| Revenue actual | 114.75M |
| Revenue Surprise | -3.88% |
Last 4 Quarters for Nature
Below you can see how NATR performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
| Release date | Jul 31, 2025 |
| Price on release | $14.01 |
| EPS estimate | $0.180 |
| EPS actual | $0.350 |
| EPS surprise | 94.44% |
| Date | Price |
|---|---|
| Jul 25, 2025 | $14.71 |
| Jul 28, 2025 | $14.73 |
| Jul 29, 2025 | $14.65 |
| Jul 30, 2025 | $14.41 |
| Jul 31, 2025 | $14.01 |
| Aug 01, 2025 | $15.80 |
| Aug 04, 2025 | $15.50 |
| Aug 05, 2025 | $15.24 |
| Aug 06, 2025 | $15.40 |
| 4 days before | -4.76% |
| 4 days after | 9.92% |
| On release day | 12.78% |
| Change in period | 4.69% |
| Release date | Nov 06, 2025 |
| Price on release | $13.67 |
| EPS estimate | $0.190 |
| EPS actual | $0.360 |
| EPS surprise | 89.47% |
| Date | Price |
|---|---|
| Oct 31, 2025 | $13.48 |
| Nov 03, 2025 | $13.76 |
| Nov 04, 2025 | $13.75 |
| Nov 05, 2025 | $14.13 |
| Nov 06, 2025 | $13.67 |
| Nov 07, 2025 | $17.92 |
| Nov 10, 2025 | $19.78 |
| Nov 11, 2025 | $20.00 |
| Nov 12, 2025 | $20.69 |
| 4 days before | 1.41% |
| 4 days after | 51.35% |
| On release day | 31.09% |
| Change in period | 53.49% |
| Release date | Mar 10, 2026 |
| Price on release | $25.08 |
| EPS estimate | $0.185 |
| EPS actual | $0.300 |
| EPS surprise | 62.16% |
| Date | Price |
|---|---|
| Mar 04, 2026 | $27.10 |
| Mar 05, 2026 | $25.84 |
| Mar 06, 2026 | $25.06 |
| Mar 09, 2026 | $25.13 |
| Mar 10, 2026 | $25.08 |
| Mar 11, 2026 | $24.76 |
| Mar 12, 2026 | $25.20 |
| Mar 13, 2026 | $24.49 |
| Mar 16, 2026 | $24.33 |
| 4 days before | -7.45% |
| 4 days after | -2.99% |
| On release day | -1.28% |
| Change in period | -10.22% |
| Release date | May 07, 2026 |
| Price on release | $24.55 |
| EPS estimate | $0.205 |
| EPS actual | $0.300 |
| EPS surprise | 46.34% |
| Date | Price |
|---|---|
| May 01, 2026 | $26.66 |
| May 04, 2026 | $26.03 |
| May 05, 2026 | $25.92 |
| May 06, 2026 | $26.24 |
| May 07, 2026 | $24.55 |
| May 08, 2026 | $24.23 |
| May 11, 2026 | $22.18 |
| May 12, 2026 | $22.43 |
| May 13, 2026 | $22.33 |
| 4 days before | -7.91% |
| 4 days after | -9.04% |
| On release day | -1.30% |
| Change in period | -16.24% |
Nature Earnings Call Transcript Summary of Q1 2026
Nature's Sunshine Products reported a strong Q1 2026: net sales of $122.9M (up 9% YoY, 7% ex-FX) and adjusted EBITDA of $14.6M (up 33%). Growth was broad-based across regions, led by North America (digital sales +42%, new digital customers +60%) and strong APAC performance (China rebound and double-digit growth in Japan and Korea). Gross margin improved to 73.2% (+116 bps) and management expects average ~73% gross margin for 2026; operating income and GAAP EPS also improved. The company reiterated full-year guidance: net sales $500–$515M (+4% to 7%) and adjusted EBITDA $50–$54M, while planning measured investments (technology, product, geographic expansion) that will ramp in Q2–Q3. Balance sheet strength is a highlight: $87.6M cash, zero debt, inventory disciplined, and $16.9M remaining on the buyback program. Management emphasized a long-term “Vision for Growth” targeting $1B revenue and a 15% EBITDA margin driven by digital expansion, supply-chain leverage, product innovation, SG&A leverage, and potential bolt-on M&A.
